scorecardresearch
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd

Aurobindo Pharma Ltd (AUROPHARMA) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 1,191,660
Feb 09, 2023 11:05 IST-
  • NSE
  • BSE
₹438.20
₹-6.85 (-1.65%)
  • Share
  • Whatsapp
  • Twitter
  • Facebook
₹437 Low
Today’s Performance
₹452 High
₹397.2 Low
52 Week’s Performance
₹727.95 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.55%
  • 1 Week 7.84%
  • 1 Month 0.79%
  • 3 Months -17.80%
  • 6 Months -21.63%
  • 1 Year -31.54%
  • 3 Years -6.37%
  • 5 Years -5.86%

PEER COMPARISON

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

Mar 11, 2022 Sell
Aurobindo Pharma Ltd ,PZENA VALUE FUNDS PLC/PZENA EMERGING MARKETS VALUE FUND
  • Qty 250294
  • Average Price ₹630.40
Mar 11, 2022 PURCHASE
Aurobindo Pharma Ltd ,PZENA VALUE FUNDS PLC/PZENA EMERGING MARKETS VALUE FUND
  • Qty 250294
  • Average Price ₹630.40
Aug 08, 2022 Sell
Aurobindo Pharma Ltd. ,ISHARES INDIA INDEX MAURITIUS COMPANY
  • Qty 311433
  • Average Price ₹568.65
Aug 08, 2022 PURCHASE
Aurobindo Pharma Ltd. ,ISHARES MSCI INDIA ETF
  • Qty 311433
  • Average Price ₹568.65
Nov 03, 2022 Sell
Aurobindo Pharma Ltd. ,ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 297309
  • Average Price ₹557.30
Nov 03, 2022 PURCHASE
Aurobindo Pharma Ltd. ,ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 297309
  • Average Price ₹557.30
Nov 14, 2022 Sell
Aurobindo Pharma Ltd. ,ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 297308
  • Average Price ₹489.30
Nov 14, 2022 PURCHASE
Aurobindo Pharma Ltd. ,ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 297308
  • Average Price ₹489.30
May 04, 2022 Sell
AUROPHARMA ,ISHARES CORE TOTAL INTERNATIONAL STOCK MAURITIUS CO
  • Qty 354384
  • Average Price ₹642.50
May 04, 2022 PURCHASE
AUROPHARMA ,ISHARES CORE MSCI TOTAL INTERNATIONAL STOCK ETF
  • Qty 354384
  • Average Price ₹642.50
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Oct 07, 2016 Sell
Aurobindo Pharma Ltd. ,SUNEELA RANI PENAKA
  • Qty 8660510
  • Average Price ₹849.30
May 30, 2014 Sell
Aurobindo Pharma Ltd. ,M/S MORGAN STANLEY ASIA SINGAPORE PTE
  • Qty 1732500
  • Average Price ₹669.92
May 30, 2014 PURCHASE
Aurobindo Pharma Ltd. ,ABU DHABI INVESTMENT AUTHORUTY - GULAB
  • Qty 1475687
  • Average Price ₹670.51
Sep 19, 2014 PURCHASE
Aurobindo Pharma Ltd. ,THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDE
  • Qty 2360231
  • Average Price ₹875.94
Aug 29, 2013 Sell
Aurobindo Pharma Ltd. ,MACQUARIE BANK LIMITED
  • Qty 1940000
  • Average Price ₹180.97
Oct 07, 2016 Sell
Aurobindo Pharma Ltd. ,SUNEELA RANI PENAKA
  • Qty 8660510
  • Average Price ₹849.30
May 30, 2014 Sell
Aurobindo Pharma Ltd. ,M/S MORGAN STANLEY ASIA SINGAPORE PTE
  • Qty 1732500
  • Average Price ₹669.92
May 30, 2014 PURCHASE
Aurobindo Pharma Ltd. ,ABU DHABI INVESTMENT AUTHORUTY - GULAB
  • Qty 1475687
  • Average Price ₹670.51
Sep 19, 2014 PURCHASE
Aurobindo Pharma Ltd. ,THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDE
  • Qty 2360231
  • Average Price ₹875.94
Aug 29, 2013 Sell
Aurobindo Pharma Ltd. ,MACQUARIE BANK LIMITED
  • Qty 1940000
  • Average Price ₹180.97
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

FAQ’S

What was Aurobindo Pharma Ltd share price previously?
Aurobindo Pharma Ltd share price was down by -1.65% from the previous closing price of ₹445.05.
Who are peers of Aurobindo Pharma Ltd?
The peers of Aurobindo Pharma Ltd are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, Lupin Ltd, Biocon Ltd, Syngene International Ltd, Gland Pharma Ltd, Ipca Laboratories Ltd, Glaxosmithkline Pharmaceuticals Ltd, Laurus Labs Ltd, J B Chemicals & Pharmaceuticals Ltd.
Who is/are the promoter/promoters of Aurobindo Pharma Ltd?
The promotor/promotors of Aurobindo Pharma Ltd are P V Ramprasad Reddy, K Nithyananda Reddy, M Sivakumaran, M Madan Mohan Reddy, P Sarath Chandra Reddy, K Ragunathan, Avnit Bimal Singh, B Adi Reddy, Savita Mahajan, Girish Paman Vanvari.
What has been 52-week high of Aurobindo Pharma Ltd stocks?
The highest price of Aurobindo Pharma Ltd stock is ₹727.95 in the last 52-week.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.